Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion type Assertion NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_head.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion description "[Inhibition of CAIX reduces the self-renewal capacity of breast cancer cells, and the combination of doxorubicin and CAIX inhibition is an attractive therapeutic strategy in basal-like and triple-negative breast cancer, which warrants further investigations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_provenance.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion evidence source_evidence_literature NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_provenance.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion SIO_000772 25422154 NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_provenance.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion wasDerivedFrom befree-2016 NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_provenance.
- NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_assertion wasGeneratedBy ECO_0000203 NP1239751.RAJYA5AzrP-V4EJtatbvMw6Cc4cvEtNI208KdXeJ42794130_provenance.